FDA Warns Websites To Stop Marketing Unapproved, Misbranded Opioids

(June 6, 2018, 8:32 AM EDT) -- SILVER SPRING — The U.S. Food and Drug Administration on June 5 warned nine online networks operating a total of 53 websites that they must stop illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications, including tramadol and oxycodone, or face injunctions or product seizures....

Related Sections